A W Bill Musk
Overview
Explore the profile of A W Bill Musk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
383
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sneddon S, Dick I, Lee Y, Musk A, Patch A, Pearson J, et al.
Lung Cancer
. 2018 Apr;
119:64-70.
PMID: 29656754
Objectives: Malignant mesothelioma (MM) is an asbestos related tumour affecting cells of serosal cavities. More than 70% of MM patients develop pleural effusions which contain tumour cells, representing a readily...
2.
Manners D, Wong P, Murray C, Teh J, Kwok Y, de Klerk N, et al.
Eur Radiol
. 2017 Jan;
27(8):3485-3490.
PMID: 28083692
Objectives: The correlation between ultra low dose computed tomography (ULDCT)-detected parenchymal lung changes and pulmonary function abnormalities is not well described. This study aimed to determine the relationship between ULDCT-detected...
3.
Murray C, Wong P, Teh J, de Klerk N, Rosenow T, Alfonso H, et al.
Respirology
. 2016 Jun;
21(8):1419-1424.
PMID: 27312516
Background And Objective: Computed tomography (CT)-based studies of asbestos-exposed individuals report a high prevalence of lung cancer, but the utility of low dose CT (LDCT) to screen asbestos-exposed populations is...
4.
Immune response profiling of malignant pleural mesothelioma for diagnostic and prognostic biomarkers
Creaney J, Dick I, Musk A, Olsen N, Robinson B
Biomarkers
. 2016 Mar;
21(6):551-61.
PMID: 27009350
The asbestos induced cancer malignant mesothelioma (MM) is difficult to diagnose and has a poor prognosis. MM is an immunological cancer, therefore autoantibodies may be suitable biomarkers and associated with...
5.
Peters S, van Oyen S, Alfonso H, Fritschi L, de Klerk N, Reid A, et al.
Ann Occup Hyg
. 2016 Mar;
60(4):533-5.
PMID: 26969295
No abstract available.
6.
Sneddon S, Leon J, Dick I, Cadby G, Olsen N, Brims F, et al.
Gene
. 2015 Mar;
563(1):103-5.
PMID: 25796603
Malignant mesothelioma (MM) is a uniformly fatal tumour caused predominantly by exposure to asbestos. It is not known why some exposed individuals get mesothelioma and others do not. There is...
7.
Creaney J, Segal A, Olsen N, Dick I, Musk A, Skates S, et al.
Dis Markers
. 2014 Dec;
2014:413946.
PMID: 25505814
Rationale: The diagnosis of pleural malignant mesothelioma (MM) by effusion cytology may be difficult and is currently controversial. Effusion mesothelin levels are increased in patients with MM but the clinical...
8.
Robinson C, Alfonso H, Woo S, Olsen N, Musk A, Robinson B, et al.
Lung Cancer
. 2014 Sep;
86(1):29-34.
PMID: 25175318
Objectives: Non-steroidal anti-inflammatory drugs (NSAIDs) and COX-2 inhibitors have been associated with lower incidence rates of some cancers. Because asbestos can cause chronic inflammation at the pleural and peritoneal surfaces...
9.
Creaney J, Dick I, Meniawy T, Leong S, Leon J, Demelker Y, et al.
Thorax
. 2014 Jul;
69(10):895-902.
PMID: 25037982
Background: Pleural malignant mesothelioma (MM) is a deadly tumour predominantly associated with asbestos exposure. A reliable diagnostic and prognostic marker for MM will significantly enhance clinical care and is an...
10.
Peters S, Reid A, Fritschi L, de Klerk N, Musk A
Occup Environ Med
. 2013 Oct;
70(12):864-8.
PMID: 24142983
Objectives: During the 1950s and 1960s, aluminium dust inhalation was used as a potential prophylaxis against silicosis in underground miners, including in Australia. We investigated the association between aluminium dust...